Discover 1,272 paid clinical trials in Tempe, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
New
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight, Chronic Weight Management
Location: Phoenix AZ, San Antonio TX, Austin TX, Evansville IN,
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All
Age: 18+
Code: NCT07743463
Phase3, Recruiting
New
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
for
Blood Loss, Surgical, Coagulation Disorder
Location: Phoenix AZ, Houston TX, Tampa FL
Sponsor: VarmX B.V.
Sex: All
Age: 18+
Code: NCT07288489
Phase3, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Phoenix AZ, Tucson AZ, Lone Tree CO, Reno NV, Eugene OR,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase2, Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
for
Endometrial Cancer
Location: Phoenix AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: Female
Age: 18 - 70
Code: NCT06481592
Phase2, Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Phoenix AZ, San Diego CA, Los Angeles CA,
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT05911568
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
for
Type B Aortic Dissection
Location: Phoenix AZ, Long Beach CA, Los Angeles CA,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT06087029
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Gilbert AZ, La Jolla CA, Oklahoma City OK, Houston TX,
Sponsor: Fate Therapeutics
Sex: All
Age: 18+
Code: NCT06241456
Phase1, Recruiting
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
for
Peripheral T-cell Lymphoma
Location: Gilbert AZ, Los Angeles CA, Dallas TX, Westwood KS,
Sponsor: CerRx, Inc.
Sex: All
Age: 18+
Code: NCT02495415
Phase2, Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
for
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma,
Location: Gilbert AZ, Greeley CO, Houston TX, The Woodlands TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00477100
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Gilbert AZ, San Diego CA, Irvine CA, Duarte CA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
for
Solid Tumor
Location: Gilbert AZ, Orange CA, Santa Monica CA, Irving TX,
Sponsor: ImmunoGenesis
Sex: All
Age: 18+
Code: NCT06014502
Phase1, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Gilbert AZ, Dallas TX, Portland OR, Seattle WA,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase1, Recruiting
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)
for
Prostate Cancer
Location: Gilbert AZ
Sponsor: University of Arizona
Sex: Male
Age: 40 - 70+
Code: NCT04228055
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Gilbert AZ, Phoenix AZ, Henderson NV, San Diego CA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Gilbert AZ, Phoenix AZ, Murrieta CA, Irvine CA,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Gilbert AZ, Oklahoma City OK, Houston TX, Detroit MI,
Sponsor: Qurgen Inc.
Sex: All
Age: 18+
Code: NCT05989724
Phase1, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Gilbert AZ, Las Vegas NV, Albuquerque NM,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for
Metastatic Non Small Cell Lung Cancer
Location: Gilbert AZ, Portland OR, Omaha NE, Sioux Falls SD,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT04614103
Phase2, Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for
Relapsed and/or Refractory B-cell Lymphoma
Location: Gilbert AZ, Duarte CA, Stanford CA, Austin TX,